Skip to main content
Fig. 12 | BMC Complementary Medicine and Therapies

Fig. 12

From: Molecular mechanism of Danshenol C in reversing peritoneal fibrosis: novel network pharmacological analysis and biological validation

Fig. 12

Effects of Danshenol C on morphology of cell and tissue A normal cells; B cells treated with 4.25%PDS for 48 h; C Danshenol C + 4.25%PDS for 48 h (D) normal peritoneal tissue of mice; E intraperitoneal injection 4.25%PDS for 28 days; F intraperitoneal injection Danshenol C + 4.25%PDS for 28 days

Back to article page